Bilateral cervical sympathetic blocks with optional integrative therapy for Special Operations veterans with PTSD and trauma-related symptoms
Official title: Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series.
Run by Reset Medical and Wellness Center · NCT07473505 · Data updated 2026-11-12
This project will try bilateral cervical sympathetic blocks (BCSB), with or without added structured integrative therapy, to see if they reduce PTSD, TBI, and other trauma-related symptoms in Special Operations veterans.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Reset Medical and Wellness Center Academic / other |
| Locations | 1 site (Strongsville, Ohio) |
| Status | Recruiting |
| Started | March 20, 2026 |
| Main results expected | February 24, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | March 20, 2026 |
| Trial ID | NCT07473505 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult Special Operations Forces veterans with PTSD (PCL score ≥33), fluent in English, willing to provide informed consent and complete study procedures, and seeking BCSB treatment are ideal candidates.
✕Probably not a fit
Patients who received any cervical sympathetic block in the past 6 months, have acute psychiatric instability, have medical contraindications to BCSB, or are enrolled in other interventional trials are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational case series enrolling Special Operations Forces veterans who independently seek bilateral cervical sympathetic blocks as part of routine care. Participants receive BCSB using standardized FDA‑approved dosing of 0.5% ropivacaine, and outcomes are compared between those who receive BCSB alone versus BCSB plus structured integrative therapy. Validated symptom measures for PTSD, TBI, anxiety, and moral injury are administered alongside strict safety monitoring. Clinical procedures are performed at RESET Medical and Wellness Center and recruitment occurs through the Operator Relief Fund intake flow without altering clinical decision-making.
Why it matters
Potential benefit: If successful, this approach could reduce PTSD and TBI-related symptoms and may provide longer-lasting symptom relief when paired with structured integrative therapy.
How similar studies have gone: Related procedures such as unilateral stellate ganglion block have shown some promising early results for PTSD symptoms, but randomized long‑term evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * PTSD (PCL Score of 33 or greater at baseline screening) * Willing and able to provide informed consent and complete study procedures * Fluent in English * Special Operations Forces Veteran Exclusion Criteria: * Recent Sympathetic Block: Receipt of any cervical sympathetic block (including stellate ganglion block \[SGB\], dual sympathetic ganglion block \[DSGB\], or bilateral SGB/BCSB), whether unilateral or bilateral, within the past 6 months. * Concurrent interventional clinical trial participation: Currently enrolled in another interventional clinical trial or receiving any experimental treatment targeting PTSD, TBI, or autonomic dysfunction during the study period * Acute Psychiatric Instability: Currently experiencing acute psychiatric crisis requiring inpatient care, active suicidal or homicidal intent, or untreated mania, psychosis, or severe dissociation * Medical Contraindications to BCSB: Any known anatomical abnormalities, bleeding disorders, allergy to local anesthetics, pregnancy, or comorbidities that represent a contraindication to receiving a cervical sympathetic block, per the treating physician's judgment. * Language or communication barriers: Inability to read, speak, or understand English sufficiently to complete informed consent and study assessments * Low PTSD Symptom Severity at Baseline: PCL-5 Score \< 33 at screening, indicating subclinical or minimal PTSD symptoms (Rationale: to ensure measurable clinical benefit and reduce floor effects)
Where it's running
-
Reset Medical and Wellness Center
Strongsville, Ohio, United States Recruiting
Study contacts
- Principal investigator: Michael Louwers, MD — Reset Medical and Wellness Center
- Study coordinator: Michael Louwers, MD
- Email: mlouwers@theresetcenter.com
- Phone: 877-737-3810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Temporal Interference Neuromodulation for Anxiety and PTSD
Aimed at seeing whether temporal interference neuromodulation can help people with anxiety or PTSD by using scalp electrodes and brain imaging to monitor mood, physiology, and cognition.
-
Behavioral health collaborative care for family members of ICU survivors in the Post-ICU clinic pilot
This pilot tests a telehealth-based behavioral health program using the NeuroFlow app for family members of ICU survivors to try to reduce anxiety, depression, and PTSD symptoms.
-
Behavioral health collaborative care for people recovering after ICU
This trial will test whether a coordinated behavioral health program using a digital app, coaching, and psychiatric support helps ICU survivors reduce anxiety, depression, and PTSD symptoms.
-
Non‑trauma PTSD treatment for veterans and service members with mild or moderate TBI
This pilot will test a non‑trauma psychotherapy program to help veterans and service members with mild or moderate traumatic brain injury who have PTSD.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.